Skip to content
Search:
Search
Facebook page opens in new window
 
ADCS
Alzheimer's Disease Cooperative Study
ADCSADCS
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • ADCS Steering Committee
    • Publications
  • Participate in Research
  • Public Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Types of Studies
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Intervention Selection Committee (ISC)
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Epstein Family Alzheimer’s Research Collaboration
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • ADCS Steering Committee
    • Publications
  • Participate in Research
  • Public Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Types of Studies
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Intervention Selection Committee (ISC)
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Epstein Family Alzheimer’s Research Collaboration

Vitamin E in Mild to Moderate AD: Can we slow down functional deterioration?

You are here:
  1. Home
  2. Research News
  3. Vitamin E in Mild to…

Although vitamin E and memantine have been shown to have beneficial effects in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD.

Post navigation

PreviousPrevious post:In the largest-ever genetic analysis conducted on Alzheimer’s disease, an international group of researchers has identified 11 new genes associated with the disorder, doubling the number of known gene variants linked to it.NextNext post:A new online report from the National Institutes of Health (NIH) highlights recent progress in NIH-supported Alzheimer’s disease research.
About ADCS
The Alzheimer’s Disease Cooperative Study (ADCS) was formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California San Diego.
Contact Us
  • E-mail:
    adcsadmin@ucsd.edu
  • Phone:
    858-246-1333

Find us on:

Facebook page opens in new windowRss page opens in new windowMail page opens in new window
Location
Shipping Address:
9452 Medical Center Drive
4th Floor
La Jolla, CA 92037

Mailing Address:
9500 Gilman Dr
MC0949
La Jolla, CA 92093-0949
Copyright 2017 Regents of the University of California.
Go to Top